Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Oragenics Inc. (OGEN)

0.5264   -0.027 (-4.88%) 02-14 16:00
Open: 0.548 Pre. Close: 0.5534
High: 0.5534 Low: 0.52
Volume: 743,262 Market Cap: 28M
Oragenics Inc is a biopharmaceutical company which engages in the discovery, development and commercialization of technologies associated with oral health, broad spectrum antibiotics and other general health benefits.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.552 - 0.555 0.555 - 0.557
Low: 0.511 - 0.515 0.515 - 0.518
Close: 0.524 - 0.53 0.53 - 0.535

Technical analysis

as of: 2020-02-14 4:31:19 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 0.74     One year: 0.90
Support: Support1: 0.42    Support2: 0.35
Resistance: Resistance1: 0.64    Resistance2: 0.77
Pivot: 0.49
Moving Average: MA(5): 0.54     MA(20): 0.48
MA(100): 0.49     MA(250): 0.53
MACD: MACD(12,26): 0.02     Signal(9): 0.01
Stochastic oscillator: %K(14,3): 31.09     %D(3): 33.22
RSI: RSI(14): 54.18
52-week: High: 0.99  Low: 0.35  Change(%): -43.4
Average Vol(K): 3-Month: 91746  10-Days: 248469

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
OGEN has closed below upper band by 36.8%. Bollinger Bands are 100.1% wider than normal. The large width of the bands suggest high volatility as compared to OGEN's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Oragenics Inc. to Present at the LD Micro 12th Annual Main Event on December 10, 2019
TAMPA, Fla.--(BUSINESS WIRE)--Oragenics Inc. to Present at the LD Micro 12th Annual Main Event on December 10, 2019

Oragenics, Inc. Publishes Peer-Reviewed Study in Journal of Peptide Science Demonstrating First Complete Chemical Synthesis of Bicyclic Ring of a Mutacin 1140 Analog
TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc Publishes Study in Journal of Peptide Science Demonstrating First Complete Chemical Synthesis of Bicyclic Ring of a Mutacin 1140 Analog

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 46.12
Shares Float (M) 41.80
% Held by Insiders 6.10
% Held by Institutions 12.68
Shares Short (K) 1570
Shares Short P. Month (K)

Stock Financials

EPS -0.387
Book Value (p.s.) 0.310
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -48.0
Return on Equity (ttm) -84.6
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.325
Qtrly Earnings Growth
Operating Cash Flow (M) -12.05
Levered Free Cash Flow (M) -7.09

Stock Valuations

P/E -1.36
P/E Growth Ratio -0.04
P/BV 1.70
P/CF -2.01

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2018-01-21
Last Split Ratio 0.1
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.